These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11213069)

  • 1. Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Paolillo JA; Boyle GJ; Law YM; Miller SA; Lawrence K; Wagner K; Pigula FA; Griffith BP; Webber SA
    Transplantation; 2001 Jan; 71(2):252-6. PubMed ID: 11213069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors.
    Ollech JE; Kramer MR; Peled N; Ollech A; Amital A; Medalion B; Saute M; Shitrit D
    Eur J Cardiothorac Surg; 2008 May; 33(5):844-8. PubMed ID: 18339554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
    Sato T; Inagaki A; Uchida K; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Tominaga Y; Okajima Y; Ohta K; Suga H; Taguchi S; Kakiya S; Itatsu T; Kobayashi T; Nakao A
    Transplantation; 2003 Nov; 76(9):1320-6. PubMed ID: 14627910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients.
    Sánchez-Pérez B; Aranda Narváez JM; Santoyo Santoyo J; Fernández-Aguilar JL; Suárez Muñoz MA; González-Sánchez AJ; Pérez Daga JA; Ramírez Plaza CP; Carrasco Campos J; Jiménez Mazure C; Becerra Ortíz R
    Transplant Proc; 2008 Nov; 40(9):2994-6. PubMed ID: 19010171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
    Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD
    Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs.
    Araki M; Flechner SM; Ismail HR; Flechner LM; Zhou L; Derweesh IH; Goldfarb D; Modlin C; Novick AC; Faiman C
    Transplantation; 2006 Feb; 81(3):335-41. PubMed ID: 16477217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management.
    First MR; Gerber DA; Hariharan S; Kaufman DB; Shapiro R
    Transplantation; 2002 Feb; 73(3):379-86. PubMed ID: 11884934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial.
    Mourad G; Glyda M; Albano L; Viklický O; Merville P; Tydén G; Mourad M; Lõhmus A; Witzke O; Christiaans MHL; Brown MW; Undre N; Kazeem G; Kuypers DRJ;
    Transplantation; 2017 Aug; 101(8):1924-1934. PubMed ID: 27547871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus.
    Numakura K; Satoh S; Tsuchiya N; Horikawa Y; Inoue T; Kakinuma H; Matsuura S; Saito M; Tada H; Suzuki T; Habuchi T
    Transplantation; 2005 Nov; 80(10):1419-24. PubMed ID: 16340785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.
    Lancia P; Adam de Beaumais T; Elie V; Garaix F; Fila M; Nobili F; Ranchin B; Testevuide P; Ulinski T; Zhao W; Deschênes G; Jacqz-Aigrain E
    Pediatr Nephrol; 2018 Jun; 33(6):1045-1055. PubMed ID: 29399716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant diabetes mellitus: the last 10 years with tacrolimus.
    Bäckman LA
    Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi13-vi16. PubMed ID: 15575021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of different immunosuppressive regimens in the development of posttransplant diabetes mellitus.
    Prokai A; Fekete A; Pasti K; Rusai K; Banki NF; Reusz G; Szabo AJ
    Pediatr Diabetes; 2012 Feb; 13(1):81-91. PubMed ID: 21595806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating mechanisms of post-transplant diabetes mellitus.
    van Hooff JP; Christiaans MH; van Duijnhoven EM
    Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi8-vi12. PubMed ID: 15575024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients.
    Numakura K; Satoh S; Tsuchiya N; Horikawa Y; Inoue T; Kakinuma H; Togashi H; Matsuura S; Tada H; Suzuki T; Habuchi T
    Transplant Proc; 2005 May; 37(4):1865-7. PubMed ID: 15919487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant diabetes mellitus: incidence and risk factors.
    Mazali FC; Lalli CA; Alves-Filho G; Mazzali M
    Transplant Proc; 2008 Apr; 40(3):764-6. PubMed ID: 18455010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplant diabetes mellitus after kidney transplantation with different immunosuppressive agents.
    Romagnoli J; Citterio F; Violi P; Nanni G; Castagneto M
    Transplant Proc; 2004 Apr; 36(3):690-1. PubMed ID: 15110632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation.
    Ramos-Cebrián M; Torregrosa JV; Gutiérrez-Dalmau A; Oppenheimer F; Campistol JM
    Transplant Proc; 2007 Sep; 39(7):2251-3. PubMed ID: 17889154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus.
    Bloom RD; Rao V; Weng F; Grossman RA; Cohen D; Mange KC
    J Am Soc Nephrol; 2002 May; 13(5):1374-80. PubMed ID: 11961026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic abnormalities in children and young adults receiving tacrolimus-based immunosuppression following cardiothoracic transplantation.
    Dobrolet NC; Webber SA; Blatt J; Michaels M; Kiaffas M; Kurland G; Boyle GJ
    Pediatr Transplant; 2001 Apr; 5(2):125-31. PubMed ID: 11328551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.